Page last updated: 2024-10-26

pentetic acid and Gliosarcoma

pentetic acid has been researched along with Gliosarcoma in 2 studies

Pentetic Acid: An iron chelating agent with properties like EDETIC ACID. DTPA has also been used as a chelator for other metals, such as plutonium.

Gliosarcoma: Rare mixed tumors of the brain and rarely the spinal cord which contain malignant neuroectodermal (glial) and mesenchymal components, including spindle-shaped fibrosarcoma cells. These tumors are highly aggressive and present primarily in adults as rapidly expanding mass lesions. They may arise in tissue that has been previously irradiated. (From Br J Neurosurg 1995 Apr;9(2):171-8)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Leber, KA1
Eder, HG1
Pendl, G1
Matsumura, A1
Shibata, Y1
Yamamoto, T1
Nakagawa, K1
Yasuda, S1
Nakajima, S1
Sakata, I1
Yoshizawa, T1
Nose, T1

Other Studies

2 other studies available for pentetic acid and Gliosarcoma

ArticleYear
Localization of superficial cerebral lesions using a magnetic resonance imaging-guided localizer.
    Minimally invasive neurosurgery : MIN, 1995, Volume: 38, Issue:2

    Topics: Brain Neoplasms; Cerebral Cortex; Contrast Media; Craniotomy; Drug Combinations; Gadolinium DTPA; Gl

1995
Mn-metalloporphyrin conjugated with Gd-DTPA (Gd-ATN10): tumor enhancement agent for magnetic resonance imaging.
    Neurologia medico-chirurgica, 1997, Volume: 37, Issue:4

    Topics: Animals; Brain; Brain Neoplasms; Contrast Media; Gadolinium DTPA; Gliosarcoma; Magnetic Resonance Im

1997